Peptide microarray of pediatric acute myeloid leukemia is related to relapse and reveals involvement of DNA damage response and repair

H Mahmud; A ter Elst; FJG Scherpen; T de Boer; KR Kampen; V de Haas; V Guryev; Maikel Peppelenbosch; SM Kornblau; ESJM de Bont

doi:10.18632/oncotarget.27086

Peptide microarray of pediatric acute myeloid leukemia is related to relapse and reveals involvement of DNA damage response and repair

H Mahmud, A ter Elst, FJG Scherpen, T de Boer, KR Kampen, V de Haas, V Guryev, Maikel Peppelenbosch, SM Kornblau, ESJM de Bont

Gastroenterology & Hepatology

Research output: Contribution to journal › Article › Academic › peer-review

5 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	4679-4690
Number of pages	12
Journal	Oncotarget
Volume	10
Issue number	45
DOIs	https://doi.org/10.18632/oncotarget.27086
Publication status	Published - 2019

Access to Document

10.18632/oncotarget.27086

Cite this

@article{4db300f1db17401093c8b2e82b2c4ab0,

title = "Peptide microarray of pediatric acute myeloid leukemia is related to relapse and reveals involvement of DNA damage response and repair",

author = "H Mahmud and {ter Elst}, A and FJG Scherpen and {de Boer}, T and KR Kampen and {de Haas}, V and V Guryev and Maikel Peppelenbosch and SM Kornblau and {de Bont}, ESJM",

year = "2019",

doi = "10.18632/oncotarget.27086",

language = "Undefined/Unknown",

volume = "10",

pages = "4679--4690",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "45",

}

TY - JOUR

T1 - Peptide microarray of pediatric acute myeloid leukemia is related to relapse and reveals involvement of DNA damage response and repair

AU - Mahmud, H

AU - ter Elst, A

AU - Scherpen, FJG

AU - de Boer, T

AU - Kampen, KR

AU - de Haas, V

AU - Guryev, V

AU - Peppelenbosch, Maikel

AU - Kornblau, SM

AU - de Bont, ESJM

PY - 2019

Y1 - 2019

U2 - 10.18632/oncotarget.27086

DO - 10.18632/oncotarget.27086

M3 - Article

SN - 1949-2553

VL - 10

SP - 4679

EP - 4690

JO - Oncotarget

JF - Oncotarget

IS - 45

ER -